Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Foehr Matthew W
Relationship:   President and CEO, Dir...
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   3,948,737    

Indirect Shares

   0      
Direct Value   $35,895,547    

Indirect Value

   $0      
Total Shares   3,948,737      
Total Value   $35,895,547      


Ligand Pharmaceuticals Inc $13,195,534 Viking Therapeutics, Inc. $6,228,888 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $16,410,126 Ligand Pharmaceuticals Inc $13,195,534 Viking Therapeutics, Inc. $6,228,888 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $16,410,126
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    4    

     Stock price went up :
    8   
    0    
     Stock price went down :
    5   
    4    
   
     Gain/Loss Ratio :
   1.6   
   -4.0   
     Percentage Gain/Loss :
   36.4%
 -89.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Former Executive Officer 2022-11-01 162,187 2011-04-18 0    Premium*  
            Viking Therapeutics, Inc. VKTX Director 2022-05-02 111,250 2015-05-04 0    Premium*  
            Qualigen Therapeutics Inc QLGN Director 2020-04-10 138,635 2015-06-24 0    Premium*  
            OmniAb, Inc OABI President and CEO, Dir... 2024-05-24 3,536,665 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    136         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2014-12-31 4 B $45.23 $2,081 D/D 46 55,016 2.66 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-24 4 OE $21.92 $1,710 D/D 78 155,491 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-24 4 AS $110.89 $8,649 D/D (78) 155,413 0 %
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2013-12-31 4 B $33.92 $2,849 D/D 84 45,013 2.66 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2014-10-10 4 B $44.91 $3,817 D/D 85 53,970 2.66 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2012-12-05 4 B $17.99 $6,656 D/D 370 37,870 2.74 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2014-06-30 4 B $43.79 $18,743 D/D 428 53,885 2.74 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-13 4 OE $21.92 $10,872 D/D 496 148,833 0 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2014-10-13 4 OE $9.97 $9,970 D/D 1,000 54,970 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2019-11-12 4 OE $21.92 $21,942 D/D 1,001 144,620 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2019-06-11 4 OE $21.92 $22,008 D/D 1,004 141,451 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2019-09-05 4 OE $21.92 $22,030 D/D 1,005 143,619 0 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2013-06-28 4 B $17.36 $18,384 D/D 1,059 44,929 2.74 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2019-08-12 4 OE $21.92 $25,493 D/D 1,163 142,614 0 -
LGND Ligand Pharmaceuticals In... EVP and COO   •       –      –    2012-06-29 4 A $10.12 $12,654 D/D 1,250 37,500 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2018-03-06 4 D $165.87 $241,673 D/D (1,457) 101,201 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-02-15 4 D $85.97 $141,163 D/D (1,642) 76,662 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-05-28 4 OE $56.26 $98,736 D/D 1,755 164,355 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-03-03 4 OE $9.97 $19,940 D/D 2,000 92,720 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-03-13 4 OE $21.92 $43,840 D/D 2,000 157,449 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-05-15 4 OE $9.97 $21,934 D/D 2,200 94,920 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-02-15 4 D $104.28 $246,831 D/D (2,367) 80,670 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-15 4 D $97.23 $241,714 D/D (2,486) 153,743 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2015-06-29 4 OE $9.97 $24,925 D/D 2,500 72,628 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-05-28 4 GD $0.00 $0 D/D 2,500 162,600 0 -
  136  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us